Quarterly ResultMay 29, 2026, 02:13 PM
Exicure Reports Q1 Net Loss of $1.83M; Raises Going Concern Doubt
AI Summary
Exicure, Inc. reported a net loss of $1.83 million for the first quarter of 2026, a significant decline from a net income of $3.01 million in the prior-year period, primarily due to the absence of a large gain on lease termination. The company's cash and cash equivalents decreased to $2.60 million, leading management to express substantial doubt about its ability to continue as a going concern without additional funding. Exicure is actively exploring strategic alternatives and faces risks related to its Nasdaq listing and ongoing legal proceedings concerning a defaulted lease.
Key Highlights
- Reported Q1 2026 net loss of $1.83 million, compared to net income of $3.01 million in Q1 2025.
- Cash and cash equivalents decreased to $2.60 million as of March 31, 2026, from $3.75 million at December 31, 2025.
- Management expressed substantial doubt about Exicure's ability to continue as a going concern.
- Exicure is exploring strategic alternatives to maximize stockholder value, including acquisitions and capital raising.
- GPCR USA completed its Phase 2 clinical trial for blood cancer patients in January 2026.
- The company intends to make a $1.0 million milestone payment to GPCR in Q2 2026 in common stock.
- Received a default notice and unlawful detainer complaint for $0.7 million in unpaid rent for its Redwood City office.
- Incorporated a new wholly-owned subsidiary, Exicure Canada Incorporated, in February 2026.
Price Impact
More from XCUR